Tryp Therapeutics (OTCQB: TRYPF) is a pharmaceutical company focused on identifying and developing clinical-stage compounds for the treatment of rare and other diseases with high unmet medical needs through regulatory pathways. CEO Gregory McKee joins us to discuss the current progress the company has had with scientific collaborations and clinical activities.

View Podcast Transcript for Tryp Therapeutics